Dengue Virus Controlled Human Challenge Reveals That Preexisting Immunity Shapes Viral Replication and Broadly Protective Responses

Scientists conducted a phase I clinical trial with 45 healthy adults to test whether secondary infection challenge with a heterotypic, full-length, attenuated dengue virus increases viremia and immunogenicity compared with primary and tertiary infection.